GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD1
|
ENSG00000170365.5 | SMAD family member 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SMAD1 | hg19_v2_chr4_+_146402925_146402957 | -0.52 | 2.0e-16 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106209368 | 116.24 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr6_-_33048483 | 99.78 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr14_-_106111127 | 78.25 |
ENST00000390545.2
|
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker) |
chr14_-_106237742 | 67.27 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr21_-_46330545 | 66.19 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr14_-_106092403 | 65.38 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr6_+_33043703 | 62.62 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr6_+_33048222 | 58.98 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr16_+_222846 | 51.56 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr19_+_39897453 | 48.41 |
ENST00000597629.1
ENST00000248673.3 ENST00000594045.1 ENST00000594442.1 |
ZFP36
|
ZFP36 ring finger protein |
chr11_-_5248294 | 45.37 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chrX_-_107018969 | 45.03 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr19_+_49838653 | 43.46 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr22_+_23264766 | 42.79 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr22_+_23247030 | 42.28 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr2_+_90077680 | 42.12 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr2_-_89310012 | 39.67 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr22_+_23241661 | 38.14 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr18_+_74240610 | 37.06 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
chr22_+_23040274 | 36.85 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr22_+_23237555 | 35.00 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr16_-_55866997 | 34.79 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
chr6_+_31583761 | 34.67 |
ENST00000376049.4
|
AIF1
|
allograft inflammatory factor 1 |
chrX_-_107019181 | 34.59 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
chr2_+_90139056 | 33.54 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr22_-_19512893 | 33.29 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
chr9_+_139871948 | 32.43 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr19_+_1065922 | 32.38 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr22_+_23243156 | 32.33 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr17_+_38083977 | 31.28 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
chr22_-_45559642 | 31.17 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
chr6_+_32709119 | 30.99 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr1_-_31230650 | 29.30 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr9_+_139874683 | 29.24 |
ENST00000444903.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr6_+_32605195 | 29.24 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr3_-_138763734 | 29.16 |
ENST00000413199.1
ENST00000502927.2 |
PRR23C
|
proline rich 23C |
chr18_+_77439775 | 28.62 |
ENST00000299543.7
ENST00000075430.7 |
CTDP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
chr14_-_106054659 | 28.34 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr2_-_89292422 | 27.91 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr22_+_22707260 | 27.67 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
chr6_-_31550192 | 27.53 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr11_+_121461097 | 26.84 |
ENST00000527934.1
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr19_-_51529849 | 26.42 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
chr19_-_54784353 | 26.13 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr2_-_89399845 | 25.97 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr22_+_23134974 | 25.89 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr19_-_17185848 | 25.85 |
ENST00000593360.1
|
HAUS8
|
HAUS augmin-like complex, subunit 8 |
chr22_-_27620603 | 25.84 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
chr17_-_29641084 | 25.74 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr19_+_55141948 | 25.72 |
ENST00000396332.4
ENST00000427581.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr16_+_226658 | 25.65 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr4_+_76439665 | 25.15 |
ENST00000508105.1
ENST00000311638.3 ENST00000380837.3 ENST00000507556.1 ENST00000504190.1 ENST00000507885.1 ENST00000502620.1 ENST00000514480.1 |
THAP6
|
THAP domain containing 6 |
chr16_+_66914264 | 25.13 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr6_-_31239846 | 24.74 |
ENST00000415537.1
ENST00000376228.5 ENST00000383329.3 |
HLA-C
|
major histocompatibility complex, class I, C |
chr9_+_139873264 | 24.64 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr18_-_47813940 | 24.62 |
ENST00000586837.1
ENST00000412036.2 ENST00000589940.1 |
CXXC1
|
CXXC finger protein 1 |
chr19_+_42381173 | 24.53 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr3_-_39322728 | 24.52 |
ENST00000541347.1
ENST00000412814.1 |
CX3CR1
|
chemokine (C-X3-C motif) receptor 1 |
chr19_-_16582815 | 23.94 |
ENST00000455140.2
ENST00000248070.6 ENST00000594975.1 |
EPS15L1
|
epidermal growth factor receptor pathway substrate 15-like 1 |
chr22_+_23101182 | 23.68 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr19_+_52901094 | 23.63 |
ENST00000391788.2
ENST00000436397.1 ENST00000391787.2 ENST00000360465.3 ENST00000494167.2 ENST00000493272.1 |
ZNF528
|
zinc finger protein 528 |
chr22_+_23229960 | 23.51 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr19_-_6690723 | 23.49 |
ENST00000601008.1
|
C3
|
complement component 3 |
chr22_+_23165153 | 23.45 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr4_-_1166954 | 23.30 |
ENST00000514490.1
ENST00000431380.1 ENST00000503765.1 |
SPON2
|
spondin 2, extracellular matrix protein |
chr2_-_99224915 | 23.27 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
chr4_+_128554081 | 23.23 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
chr16_+_3115323 | 22.79 |
ENST00000531965.1
ENST00000396887.3 ENST00000529699.1 ENST00000526464.2 ENST00000440815.3 |
IL32
|
interleukin 32 |
chr6_-_74161977 | 22.62 |
ENST00000370318.1
ENST00000370315.3 |
MB21D1
|
Mab-21 domain containing 1 |
chr11_-_2323290 | 22.58 |
ENST00000381153.3
|
C11orf21
|
chromosome 11 open reading frame 21 |
chr2_-_87017985 | 22.48 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
chr2_+_241564655 | 22.37 |
ENST00000407714.1
|
GPR35
|
G protein-coupled receptor 35 |
chr11_+_1891380 | 22.35 |
ENST00000429923.1
ENST00000418975.1 ENST00000406638.2 |
LSP1
|
lymphocyte-specific protein 1 |
chr3_+_156544057 | 22.23 |
ENST00000498839.1
ENST00000470811.1 ENST00000356539.4 ENST00000483177.1 ENST00000477399.1 ENST00000491763.1 |
LEKR1
|
leucine, glutamate and lysine rich 1 |
chr9_-_97401782 | 22.16 |
ENST00000375326.4
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
chr14_-_106174960 | 21.92 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr22_+_23077065 | 21.88 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr2_-_89278535 | 21.84 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr1_-_204380919 | 21.75 |
ENST00000367188.4
|
PPP1R15B
|
protein phosphatase 1, regulatory subunit 15B |
chr5_-_172198190 | 21.71 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr11_+_2323349 | 21.47 |
ENST00000381121.3
|
TSPAN32
|
tetraspanin 32 |
chr2_-_89513402 | 21.44 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr3_-_46506563 | 21.42 |
ENST00000231751.4
|
LTF
|
lactotransferrin |
chr16_+_3115298 | 21.41 |
ENST00000325568.5
ENST00000534507.1 |
IL32
|
interleukin 32 |
chr19_-_51875894 | 21.38 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr19_+_42381337 | 21.37 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr13_-_30881621 | 21.31 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chr22_+_22681656 | 21.17 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr16_+_3115378 | 21.04 |
ENST00000529550.1
ENST00000551122.1 ENST00000525643.2 ENST00000548807.1 ENST00000528163.2 |
IL32
|
interleukin 32 |
chr16_+_30483962 | 20.87 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr19_+_1067271 | 20.86 |
ENST00000536472.1
ENST00000590214.1 |
HMHA1
|
histocompatibility (minor) HA-1 |
chr19_+_1077393 | 20.81 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chrX_+_70586140 | 20.79 |
ENST00000276072.3
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa |
chr1_+_152635854 | 20.75 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
chr19_+_16435625 | 20.70 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr5_-_131826457 | 20.59 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
chr6_+_31582961 | 20.50 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
chr11_+_695614 | 20.47 |
ENST00000608174.1
ENST00000397512.3 |
TMEM80
|
transmembrane protein 80 |
chr17_-_29641104 | 20.35 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr7_-_150038704 | 20.33 |
ENST00000466675.1
ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2 |
chr11_+_695787 | 20.16 |
ENST00000526170.1
ENST00000488769.1 |
TMEM80
|
transmembrane protein 80 |
chr15_+_89181974 | 20.03 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr4_-_681114 | 19.99 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
chr2_-_87018784 | 19.97 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
chr2_-_11272234 | 19.76 |
ENST00000590207.1
ENST00000417697.2 ENST00000396164.1 ENST00000536743.1 ENST00000544306.1 |
AC062028.1
|
AC062028.1 |
chr17_-_80275417 | 19.71 |
ENST00000583376.1
ENST00000578509.1 ENST00000584284.1 ENST00000582480.1 |
CD7
|
CD7 molecule |
chr3_+_183967409 | 19.52 |
ENST00000324557.4
ENST00000402825.3 |
ECE2
|
endothelin converting enzyme 2 |
chr3_+_45071622 | 19.45 |
ENST00000428034.1
|
CLEC3B
|
C-type lectin domain family 3, member B |
chr4_-_1166623 | 19.42 |
ENST00000290902.5
|
SPON2
|
spondin 2, extracellular matrix protein |
chr15_+_75074410 | 19.33 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
chr19_-_12662240 | 19.30 |
ENST00000416136.1
ENST00000428311.1 |
ZNF564
ZNF709
|
zinc finger protein 564 ZNF709 |
chr17_-_40021656 | 19.10 |
ENST00000319121.3
|
KLHL11
|
kelch-like family member 11 |
chr2_-_89521942 | 19.07 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr16_+_30484021 | 18.99 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr12_+_6898638 | 18.99 |
ENST00000011653.4
|
CD4
|
CD4 molecule |
chr10_+_38299546 | 18.84 |
ENST00000374618.3
ENST00000432900.2 ENST00000458705.2 ENST00000469037.2 |
ZNF33A
|
zinc finger protein 33A |
chr17_-_79269067 | 18.75 |
ENST00000288439.5
ENST00000374759.3 |
SLC38A10
|
solute carrier family 38, member 10 |
chr1_+_28206150 | 18.73 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
chr12_+_7055631 | 18.72 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr17_+_34431212 | 18.70 |
ENST00000394495.1
|
CCL4
|
chemokine (C-C motif) ligand 4 |
chr17_-_37844267 | 18.68 |
ENST00000579146.1
ENST00000378011.4 ENST00000429199.2 ENST00000300658.4 |
PGAP3
|
post-GPI attachment to proteins 3 |
chr2_-_89340242 | 18.67 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr11_-_66360548 | 18.63 |
ENST00000333861.3
|
CCDC87
|
coiled-coil domain containing 87 |
chr5_+_54398463 | 18.54 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
chr19_-_6481776 | 18.46 |
ENST00000543576.1
ENST00000590173.1 ENST00000381480.2 |
DENND1C
|
DENN/MADD domain containing 1C |
chr2_+_89923550 | 18.46 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chrX_-_19002696 | 18.46 |
ENST00000379942.4
|
PHKA2
|
phosphorylase kinase, alpha 2 (liver) |
chr13_+_25338290 | 18.38 |
ENST00000255324.5
ENST00000381921.1 ENST00000255325.6 |
RNF17
|
ring finger protein 17 |
chr3_+_153839149 | 18.32 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr20_-_23066953 | 18.29 |
ENST00000246006.4
|
CD93
|
CD93 molecule |
chr3_+_40566369 | 18.20 |
ENST00000403205.2
ENST00000310898.1 ENST00000339296.5 ENST00000431278.1 |
ZNF621
|
zinc finger protein 621 |
chr2_-_89442621 | 18.14 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr17_+_77681075 | 18.08 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
chr1_+_153330322 | 17.97 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr7_+_100136811 | 17.96 |
ENST00000300176.4
ENST00000262935.4 |
AGFG2
|
ArfGAP with FG repeats 2 |
chr15_+_81589254 | 17.94 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr2_+_89901292 | 17.92 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr11_-_18034701 | 17.91 |
ENST00000265965.5
|
SERGEF
|
secretion regulating guanine nucleotide exchange factor |
chr19_+_45973120 | 17.87 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr2_-_89459813 | 17.86 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr11_+_1889880 | 17.83 |
ENST00000405957.2
|
LSP1
|
lymphocyte-specific protein 1 |
chr1_-_27961720 | 17.83 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr19_-_51587502 | 17.82 |
ENST00000156499.2
ENST00000391802.1 |
KLK14
|
kallikrein-related peptidase 14 |
chr21_-_46340770 | 17.74 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr5_-_169725231 | 17.74 |
ENST00000046794.5
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr11_-_67205538 | 17.68 |
ENST00000326294.3
|
PTPRCAP
|
protein tyrosine phosphatase, receptor type, C-associated protein |
chr1_-_161600990 | 17.56 |
ENST00000531221.1
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chr16_-_55867146 | 17.42 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
chr19_-_16582754 | 17.42 |
ENST00000602151.1
ENST00000597937.1 ENST00000535753.2 |
EPS15L1
|
epidermal growth factor receptor pathway substrate 15-like 1 |
chr14_-_107083690 | 17.31 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr11_+_124492749 | 17.23 |
ENST00000531667.1
ENST00000441174.3 ENST00000375005.4 |
TBRG1
|
transforming growth factor beta regulator 1 |
chr19_+_859425 | 17.21 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
chr19_-_36231437 | 17.18 |
ENST00000591748.1
|
IGFLR1
|
IGF-like family receptor 1 |
chr1_-_52831796 | 17.17 |
ENST00000284376.3
ENST00000438831.1 ENST00000371586.2 |
CC2D1B
|
coiled-coil and C2 domain containing 1B |
chr4_-_156875003 | 17.12 |
ENST00000433477.3
|
CTSO
|
cathepsin O |
chr17_-_62009621 | 17.12 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr1_+_32739733 | 17.09 |
ENST00000333070.4
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr2_+_131113609 | 17.08 |
ENST00000347849.3
|
PTPN18
|
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
chr11_+_2421718 | 17.03 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
chr9_+_134378289 | 16.99 |
ENST00000423007.1
ENST00000404875.2 ENST00000441334.1 ENST00000341012.7 ENST00000372228.3 ENST00000402686.3 ENST00000419118.2 ENST00000541219.1 ENST00000354713.4 ENST00000418774.1 ENST00000415075.1 ENST00000448212.1 ENST00000430619.1 |
POMT1
|
protein-O-mannosyltransferase 1 |
chr14_-_94854926 | 16.93 |
ENST00000402629.1
ENST00000556091.1 ENST00000554720.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr21_-_46340884 | 16.87 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr14_-_106322288 | 16.82 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr1_+_16767167 | 16.76 |
ENST00000337132.5
|
NECAP2
|
NECAP endocytosis associated 2 |
chr16_-_30032610 | 16.72 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
chr14_-_106692191 | 16.69 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
chr6_-_159420780 | 16.67 |
ENST00000449822.1
|
RSPH3
|
radial spoke 3 homolog (Chlamydomonas) |
chr2_-_128568721 | 16.63 |
ENST00000322313.4
ENST00000393006.1 ENST00000409658.3 ENST00000436787.1 |
WDR33
|
WD repeat domain 33 |
chr2_+_90108504 | 16.62 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr2_+_89999259 | 16.62 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr17_-_62009702 | 16.60 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr2_-_89266286 | 16.59 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr2_+_85921522 | 16.57 |
ENST00000409696.3
|
GNLY
|
granulysin |
chr17_-_62084241 | 16.49 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
chr19_-_36643329 | 16.48 |
ENST00000589154.1
|
COX7A1
|
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
chr19_-_36297632 | 16.46 |
ENST00000588266.2
|
PRODH2
|
proline dehydrogenase (oxidase) 2 |
chr9_-_97402413 | 16.42 |
ENST00000414122.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
chr7_+_73623717 | 16.35 |
ENST00000344995.5
ENST00000460943.1 |
LAT2
|
linker for activation of T cells family, member 2 |
chrX_+_70586082 | 16.32 |
ENST00000373790.4
ENST00000449580.1 ENST00000423759.1 |
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa |
chr16_-_25122785 | 16.31 |
ENST00000563962.1
ENST00000569920.1 |
RP11-449H11.1
|
RP11-449H11.1 |
chr5_+_157170703 | 16.30 |
ENST00000286307.5
|
LSM11
|
LSM11, U7 small nuclear RNA associated |
chr14_-_81687197 | 16.26 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr2_-_89619904 | 16.20 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr11_+_2323236 | 16.19 |
ENST00000182290.4
|
TSPAN32
|
tetraspanin 32 |
chr6_-_31324943 | 16.18 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr17_-_80275466 | 16.18 |
ENST00000312648.3
|
CD7
|
CD7 molecule |
chr17_-_71410794 | 16.17 |
ENST00000424778.1
|
SDK2
|
sidekick cell adhesion molecule 2 |
chr6_+_29691198 | 16.11 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr7_+_26438187 | 16.10 |
ENST00000439120.1
ENST00000430548.1 ENST00000421862.1 ENST00000449537.1 ENST00000420774.1 ENST00000418758.2 |
AC004540.5
|
AC004540.5 |
chr19_+_45417921 | 16.06 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
chr17_-_62097927 | 16.06 |
ENST00000578313.1
ENST00000584084.1 ENST00000579788.1 ENST00000579687.1 ENST00000578379.1 ENST00000578892.1 ENST00000412356.1 ENST00000418105.1 |
ICAM2
|
intercellular adhesion molecule 2 |
chr5_-_149492904 | 16.03 |
ENST00000286301.3
ENST00000511344.1 |
CSF1R
|
colony stimulating factor 1 receptor |
chr19_+_15752088 | 16.03 |
ENST00000585846.1
|
CYP4F3
|
cytochrome P450, family 4, subfamily F, polypeptide 3 |
chr1_-_38157877 | 16.02 |
ENST00000477060.1
ENST00000491981.1 ENST00000488137.1 |
C1orf109
|
chromosome 1 open reading frame 109 |
chr11_+_71927807 | 16.01 |
ENST00000298223.6
ENST00000454954.2 ENST00000541003.1 ENST00000539412.1 ENST00000536778.1 ENST00000535625.1 ENST00000321324.7 |
FOLR2
|
folate receptor 2 (fetal) |
chr19_-_58326267 | 16.01 |
ENST00000391701.1
|
ZNF552
|
zinc finger protein 552 |
chr17_-_41465674 | 15.97 |
ENST00000592135.1
ENST00000587874.1 ENST00000588654.1 ENST00000592094.1 |
LINC00910
|
long intergenic non-protein coding RNA 910 |
chr19_+_50922187 | 15.95 |
ENST00000595883.1
ENST00000597855.1 ENST00000596074.1 ENST00000439922.2 ENST00000594685.1 ENST00000270632.7 |
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr2_-_158345462 | 15.87 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
chr11_-_73694346 | 15.85 |
ENST00000310473.3
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.0 | 68.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
16.5 | 49.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
15.9 | 47.8 | GO:1900159 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
13.7 | 54.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
13.1 | 39.4 | GO:1902955 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
13.0 | 38.9 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
12.8 | 38.3 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
12.6 | 50.3 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
12.3 | 61.7 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
12.2 | 36.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
11.8 | 94.2 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
11.1 | 44.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
10.8 | 43.4 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
10.7 | 42.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
10.6 | 21.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
10.6 | 95.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
10.3 | 51.7 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
10.2 | 724.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
10.1 | 10.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
10.0 | 30.1 | GO:0002818 | intracellular defense response(GO:0002818) |
9.5 | 28.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
9.4 | 9.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
9.2 | 9.2 | GO:0035878 | nail development(GO:0035878) |
8.8 | 26.4 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
8.5 | 51.1 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
8.5 | 17.0 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
8.5 | 25.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
8.4 | 25.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
8.3 | 41.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
8.2 | 33.0 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
8.1 | 24.4 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
8.1 | 24.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
7.9 | 31.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
7.7 | 7.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
7.6 | 60.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
7.6 | 45.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
7.4 | 44.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
7.3 | 43.8 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
7.2 | 43.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
7.2 | 21.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
7.1 | 21.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
7.1 | 141.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
7.0 | 7.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
6.9 | 20.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
6.8 | 6.8 | GO:0070666 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
6.6 | 616.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
6.4 | 6.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
6.4 | 19.1 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
6.3 | 19.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
6.3 | 50.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
6.3 | 31.3 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
6.0 | 18.0 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
5.9 | 5.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
5.8 | 17.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
5.7 | 17.1 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
5.7 | 17.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
5.7 | 51.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
5.6 | 5.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
5.6 | 22.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
5.6 | 5.6 | GO:0006000 | fructose metabolic process(GO:0006000) fructose 1,6-bisphosphate metabolic process(GO:0030388) |
5.6 | 27.8 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
5.4 | 21.7 | GO:0090677 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
5.4 | 5.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
5.4 | 21.5 | GO:0015942 | formate metabolic process(GO:0015942) |
5.3 | 26.5 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
5.3 | 26.4 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
5.2 | 10.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
5.2 | 15.6 | GO:0071529 | cementum mineralization(GO:0071529) |
5.2 | 5.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
5.1 | 10.1 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
5.0 | 15.0 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
4.9 | 24.6 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
4.9 | 29.3 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
4.9 | 14.6 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
4.8 | 4.8 | GO:0007435 | salivary gland morphogenesis(GO:0007435) |
4.8 | 19.3 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
4.8 | 86.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
4.8 | 23.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
4.7 | 47.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
4.7 | 14.1 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
4.7 | 23.4 | GO:0072144 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
4.7 | 4.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
4.6 | 64.2 | GO:0015671 | oxygen transport(GO:0015671) |
4.6 | 13.7 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
4.5 | 4.5 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
4.5 | 13.4 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
4.3 | 52.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
4.3 | 12.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
4.3 | 17.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
4.3 | 29.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
4.2 | 16.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
4.2 | 12.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
4.1 | 20.6 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
4.1 | 8.2 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
4.1 | 4.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
4.1 | 12.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
4.0 | 16.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
4.0 | 12.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
4.0 | 12.0 | GO:1990502 | dense core granule maturation(GO:1990502) |
4.0 | 15.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
4.0 | 4.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
3.9 | 3.9 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
3.9 | 3.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
3.9 | 55.0 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
3.9 | 11.6 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
3.9 | 19.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
3.8 | 19.0 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
3.8 | 11.3 | GO:0043366 | beta selection(GO:0043366) |
3.7 | 11.2 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
3.7 | 22.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
3.7 | 11.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
3.7 | 18.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
3.6 | 21.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
3.6 | 25.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
3.6 | 25.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
3.6 | 10.7 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
3.6 | 21.3 | GO:0051013 | microtubule severing(GO:0051013) |
3.5 | 17.7 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
3.5 | 10.6 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
3.5 | 7.0 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
3.5 | 10.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
3.5 | 10.4 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
3.5 | 13.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
3.5 | 3.5 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
3.5 | 6.9 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
3.4 | 13.7 | GO:0048749 | compound eye development(GO:0048749) |
3.4 | 379.7 | GO:0031295 | T cell costimulation(GO:0031295) |
3.3 | 6.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
3.3 | 19.9 | GO:0030035 | microspike assembly(GO:0030035) |
3.3 | 16.6 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
3.3 | 19.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
3.3 | 3.3 | GO:0032606 | regulation of type I interferon production(GO:0032479) type I interferon production(GO:0032606) |
3.3 | 13.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
3.3 | 16.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
3.2 | 6.5 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
3.2 | 6.4 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
3.2 | 3.2 | GO:0009896 | positive regulation of catabolic process(GO:0009896) |
3.2 | 25.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
3.2 | 3.2 | GO:0060594 | mammary gland specification(GO:0060594) |
3.1 | 6.3 | GO:0002384 | hepatic immune response(GO:0002384) |
3.1 | 9.4 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
3.1 | 6.3 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
3.1 | 6.2 | GO:0070543 | response to linoleic acid(GO:0070543) |
3.1 | 9.3 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
3.1 | 12.4 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
3.1 | 18.6 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
3.1 | 30.9 | GO:1990403 | embryonic brain development(GO:1990403) |
3.1 | 9.3 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
3.1 | 6.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
3.1 | 30.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
3.1 | 9.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
3.0 | 9.1 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
3.0 | 18.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
3.0 | 18.2 | GO:0015811 | L-cystine transport(GO:0015811) |
3.0 | 15.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
3.0 | 24.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
3.0 | 9.0 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
3.0 | 9.0 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
3.0 | 12.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
3.0 | 6.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
3.0 | 23.9 | GO:0015705 | iodide transport(GO:0015705) |
3.0 | 23.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
3.0 | 5.9 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
3.0 | 11.8 | GO:0032053 | ciliary basal body organization(GO:0032053) |
2.9 | 2.9 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
2.9 | 8.8 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
2.9 | 2.9 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
2.9 | 11.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.9 | 14.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
2.9 | 5.8 | GO:0098780 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
2.9 | 8.7 | GO:0070842 | aggresome assembly(GO:0070842) |
2.9 | 59.9 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
2.8 | 28.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
2.8 | 8.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
2.8 | 11.3 | GO:0051866 | general adaptation syndrome(GO:0051866) |
2.8 | 11.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.8 | 11.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
2.8 | 19.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
2.8 | 2.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.8 | 8.3 | GO:0010332 | response to gamma radiation(GO:0010332) |
2.7 | 2.7 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
2.7 | 5.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
2.7 | 5.4 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
2.7 | 8.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
2.7 | 10.8 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
2.7 | 8.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
2.7 | 5.4 | GO:0071224 | positive regulation of immature T cell proliferation(GO:0033091) cellular response to peptidoglycan(GO:0071224) |
2.7 | 2.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
2.7 | 10.7 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
2.7 | 5.4 | GO:0002266 | follicular dendritic cell activation(GO:0002266) |
2.7 | 18.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.7 | 42.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
2.7 | 24.0 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
2.7 | 8.0 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) |
2.7 | 13.3 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
2.6 | 7.9 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
2.6 | 10.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
2.6 | 2.6 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
2.6 | 10.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
2.6 | 2.6 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
2.6 | 10.4 | GO:0001825 | blastocyst formation(GO:0001825) |
2.6 | 20.9 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
2.6 | 2.6 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
2.6 | 10.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
2.6 | 53.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
2.6 | 15.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
2.5 | 5.0 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
2.5 | 10.1 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
2.5 | 65.4 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
2.5 | 20.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
2.5 | 15.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
2.5 | 125.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
2.5 | 10.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
2.5 | 15.0 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
2.5 | 7.5 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
2.5 | 5.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
2.5 | 9.9 | GO:0030279 | negative regulation of ossification(GO:0030279) |
2.5 | 2.5 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
2.5 | 2.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
2.5 | 4.9 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
2.5 | 14.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
2.4 | 7.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
2.4 | 4.9 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
2.4 | 79.9 | GO:0006536 | glutamate metabolic process(GO:0006536) |
2.4 | 4.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
2.4 | 7.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.4 | 4.8 | GO:0002027 | regulation of heart rate(GO:0002027) |
2.4 | 4.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
2.4 | 23.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
2.4 | 12.0 | GO:0046968 | peptide antigen transport(GO:0046968) |
2.4 | 4.8 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
2.4 | 7.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.4 | 19.1 | GO:0006116 | NADH oxidation(GO:0006116) |
2.4 | 9.5 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
2.4 | 16.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
2.4 | 7.1 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
2.3 | 7.0 | GO:0097359 | UDP-glucosylation(GO:0097359) |
2.3 | 2.3 | GO:0032571 | response to vitamin K(GO:0032571) |
2.3 | 2.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
2.3 | 2.3 | GO:0030317 | sperm motility(GO:0030317) |
2.3 | 7.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
2.3 | 9.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.3 | 16.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
2.3 | 6.9 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
2.3 | 6.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
2.3 | 9.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
2.3 | 16.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
2.3 | 6.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
2.3 | 6.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
2.3 | 9.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
2.3 | 9.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
2.3 | 6.8 | GO:1904529 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
2.2 | 2.2 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
2.2 | 13.4 | GO:0006477 | protein sulfation(GO:0006477) |
2.2 | 15.6 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
2.2 | 15.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.2 | 28.7 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
2.2 | 4.4 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.2 | 6.6 | GO:0008355 | olfactory learning(GO:0008355) |
2.2 | 6.6 | GO:0003218 | cardiac left ventricle formation(GO:0003218) cell migration involved in vasculogenesis(GO:0035441) |
2.2 | 8.8 | GO:0009450 | gamma-aminobutyric acid biosynthetic process(GO:0009449) gamma-aminobutyric acid catabolic process(GO:0009450) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
2.2 | 11.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.2 | 2.2 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
2.2 | 4.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
2.2 | 13.0 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
2.2 | 10.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
2.2 | 43.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
2.1 | 6.4 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
2.1 | 10.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.1 | 6.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
2.1 | 10.7 | GO:0050808 | synapse organization(GO:0050808) |
2.1 | 17.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
2.1 | 12.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.1 | 6.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.1 | 27.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
2.1 | 2.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
2.1 | 21.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
2.1 | 8.4 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
2.1 | 21.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
2.1 | 6.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
2.1 | 18.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.1 | 6.2 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
2.1 | 4.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
2.1 | 6.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
2.1 | 35.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
2.1 | 2.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
2.0 | 6.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
2.0 | 16.4 | GO:1903416 | response to glycoside(GO:1903416) |
2.0 | 12.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.0 | 8.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.0 | 6.1 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
2.0 | 12.2 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
2.0 | 14.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
2.0 | 4.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
2.0 | 16.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
2.0 | 4.0 | GO:0019233 | sensory perception of pain(GO:0019233) |
2.0 | 16.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
2.0 | 4.0 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
2.0 | 12.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
2.0 | 12.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
2.0 | 9.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
2.0 | 59.1 | GO:0045730 | respiratory burst(GO:0045730) |
2.0 | 19.7 | GO:0019835 | cytolysis(GO:0019835) |
2.0 | 9.8 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
2.0 | 5.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
2.0 | 2.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
1.9 | 13.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
1.9 | 5.8 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.9 | 7.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.9 | 15.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.9 | 5.8 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
1.9 | 19.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.9 | 246.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.9 | 13.4 | GO:0045007 | depurination(GO:0045007) |
1.9 | 1.9 | GO:0035962 | response to interleukin-13(GO:0035962) |
1.9 | 20.9 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.9 | 3.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.9 | 13.2 | GO:0042426 | choline catabolic process(GO:0042426) |
1.9 | 7.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
1.9 | 7.5 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
1.9 | 26.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.9 | 18.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
1.9 | 3.7 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
1.8 | 1.8 | GO:0045726 | regulation of integrin biosynthetic process(GO:0045113) positive regulation of integrin biosynthetic process(GO:0045726) positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
1.8 | 5.5 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
1.8 | 11.0 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
1.8 | 1.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
1.8 | 5.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.8 | 36.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.8 | 1.8 | GO:0007635 | chemosensory behavior(GO:0007635) |
1.8 | 5.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.8 | 9.0 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
1.8 | 18.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.8 | 5.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
1.8 | 3.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.8 | 9.0 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.8 | 7.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.8 | 21.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.8 | 3.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.8 | 10.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
1.8 | 7.1 | GO:0042335 | cuticle development(GO:0042335) |
1.7 | 28.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
1.7 | 5.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
1.7 | 6.9 | GO:0018377 | protein myristoylation(GO:0018377) |
1.7 | 8.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.7 | 12.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
1.7 | 6.8 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
1.7 | 3.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.7 | 5.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.7 | 6.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
1.7 | 5.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.7 | 6.6 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
1.7 | 9.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.6 | 4.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.6 | 9.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.6 | 4.9 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.6 | 21.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.6 | 13.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.6 | 9.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.6 | 6.5 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
1.6 | 6.5 | GO:0051608 | histamine transport(GO:0051608) |
1.6 | 44.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
1.6 | 1.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
1.6 | 4.9 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.6 | 4.9 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
1.6 | 9.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.6 | 4.8 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
1.6 | 11.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
1.6 | 1.6 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.6 | 9.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.6 | 12.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.6 | 3.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
1.6 | 9.4 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
1.6 | 1.6 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.6 | 4.7 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.6 | 6.2 | GO:1904179 | positive regulation of cardiac conduction(GO:1903781) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) positive regulation of adipose tissue development(GO:1904179) positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
1.6 | 7.8 | GO:0035799 | ureter maturation(GO:0035799) |
1.5 | 4.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
1.5 | 6.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
1.5 | 3.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.5 | 7.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.5 | 4.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.5 | 4.6 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
1.5 | 15.3 | GO:0015889 | cobalt ion transport(GO:0006824) cobalamin transport(GO:0015889) |
1.5 | 3.0 | GO:1904996 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.5 | 6.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
1.5 | 1.5 | GO:0070989 | oxidative demethylation(GO:0070989) |
1.5 | 4.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.5 | 30.2 | GO:0097503 | sialylation(GO:0097503) |
1.5 | 22.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.5 | 4.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.5 | 6.0 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
1.5 | 13.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.5 | 7.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
1.5 | 53.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
1.5 | 9.0 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
1.5 | 4.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
1.5 | 4.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
1.5 | 5.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.5 | 16.2 | GO:0030238 | male sex determination(GO:0030238) |
1.5 | 16.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.5 | 35.3 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
1.5 | 8.8 | GO:0071104 | response to interleukin-9(GO:0071104) |
1.5 | 19.1 | GO:0014029 | neural crest formation(GO:0014029) |
1.5 | 61.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.5 | 4.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.5 | 2.9 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.4 | 2.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.4 | 4.3 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
1.4 | 1.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
1.4 | 7.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.4 | 4.3 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.4 | 2.8 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
1.4 | 4.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.4 | 9.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.4 | 5.6 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.4 | 5.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.4 | 8.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.4 | 13.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.4 | 15.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.4 | 5.5 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.4 | 6.9 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
1.4 | 8.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
1.4 | 11.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
1.4 | 22.0 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
1.4 | 4.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.4 | 1.4 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
1.4 | 11.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.4 | 2.7 | GO:0030850 | prostate gland development(GO:0030850) |
1.4 | 10.9 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.4 | 55.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.4 | 6.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.4 | 5.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
1.4 | 6.8 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
1.3 | 13.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.3 | 1.3 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.3 | 2.7 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
1.3 | 6.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
1.3 | 5.4 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
1.3 | 9.4 | GO:0060534 | trachea cartilage development(GO:0060534) |
1.3 | 5.3 | GO:0060197 | cloacal septation(GO:0060197) |
1.3 | 2.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
1.3 | 14.6 | GO:0032364 | oxygen homeostasis(GO:0032364) |
1.3 | 2.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.3 | 7.9 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
1.3 | 4.0 | GO:0030324 | lung development(GO:0030324) |
1.3 | 2.6 | GO:0061009 | common bile duct development(GO:0061009) |
1.3 | 2.6 | GO:0018343 | protein farnesylation(GO:0018343) |
1.3 | 2.6 | GO:0036269 | swimming behavior(GO:0036269) |
1.3 | 14.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
1.3 | 2.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.3 | 1.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.3 | 9.1 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
1.3 | 5.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.3 | 6.4 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
1.3 | 2.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
1.3 | 3.8 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
1.3 | 7.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
1.3 | 3.8 | GO:0072716 | response to actinomycin D(GO:0072716) |
1.3 | 2.5 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
1.3 | 2.5 | GO:0010193 | response to ozone(GO:0010193) |
1.3 | 2.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
1.3 | 2.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
1.3 | 1.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
1.2 | 5.0 | GO:0030242 | pexophagy(GO:0030242) |
1.2 | 3.7 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.2 | 7.5 | GO:0001554 | luteolysis(GO:0001554) |
1.2 | 6.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
1.2 | 6.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
1.2 | 5.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.2 | 8.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.2 | 33.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.2 | 11.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.2 | 3.7 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
1.2 | 1.2 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
1.2 | 7.4 | GO:2000052 | regulation of non-canonical Wnt signaling pathway(GO:2000050) positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.2 | 55.4 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
1.2 | 6.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
1.2 | 9.8 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.2 | 6.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.2 | 13.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.2 | 3.7 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
1.2 | 9.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
1.2 | 7.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.2 | 6.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.2 | 4.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.2 | 9.6 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
1.2 | 7.2 | GO:0042048 | olfactory behavior(GO:0042048) |
1.2 | 3.6 | GO:0070781 | response to biotin(GO:0070781) |
1.2 | 2.4 | GO:0000023 | maltose metabolic process(GO:0000023) |
1.2 | 22.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.2 | 10.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.2 | 2.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.2 | 4.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
1.2 | 8.3 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
1.2 | 2.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.2 | 3.5 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
1.2 | 3.5 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) negative regulation of nuclear division(GO:0051784) |
1.2 | 8.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.2 | 3.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
1.2 | 3.5 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.2 | 3.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
1.2 | 7.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.2 | 15.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
1.2 | 2.3 | GO:0048599 | oocyte development(GO:0048599) |
1.2 | 8.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.2 | 3.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.2 | 4.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.2 | 21.9 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
1.2 | 3.5 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
1.2 | 1.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.1 | 2.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.1 | 3.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.1 | 8.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.1 | 1.1 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
1.1 | 6.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.1 | 1.1 | GO:0060326 | cell chemotaxis(GO:0060326) |
1.1 | 5.7 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.1 | 3.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
1.1 | 3.4 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
1.1 | 3.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
1.1 | 5.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.1 | 6.8 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
1.1 | 6.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.1 | 2.2 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
1.1 | 10.0 | GO:0071313 | cellular response to caffeine(GO:0071313) |
1.1 | 1.1 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
1.1 | 4.4 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.1 | 1.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
1.1 | 2.2 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
1.1 | 15.5 | GO:1903510 | mucopolysaccharide metabolic process(GO:1903510) |
1.1 | 7.7 | GO:0048820 | hair follicle maturation(GO:0048820) |
1.1 | 11.0 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
1.1 | 9.9 | GO:0015747 | urate transport(GO:0015747) |
1.1 | 14.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.1 | 9.8 | GO:0015074 | DNA integration(GO:0015074) |
1.1 | 3.3 | GO:0032094 | response to food(GO:0032094) |
1.1 | 5.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.1 | 16.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.1 | 2.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
1.1 | 5.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.1 | 1.1 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
1.1 | 1.1 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
1.1 | 6.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.1 | 2.2 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.1 | 13.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
1.1 | 7.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
1.1 | 3.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.1 | 15.0 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
1.1 | 1.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
1.1 | 8.5 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
1.1 | 2.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.1 | 5.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.1 | 4.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
1.0 | 4.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
1.0 | 4.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.0 | 2.1 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
1.0 | 11.5 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.0 | 7.3 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
1.0 | 6.2 | GO:0072677 | eosinophil migration(GO:0072677) |
1.0 | 3.1 | GO:0097477 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
1.0 | 11.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.0 | 5.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.0 | 4.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.0 | 2.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.0 | 6.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
1.0 | 1.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.0 | 14.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
1.0 | 11.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.0 | 4.1 | GO:0036035 | osteoclast development(GO:0036035) |
1.0 | 5.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.0 | 3.0 | GO:0060348 | bone development(GO:0060348) |
1.0 | 12.1 | GO:0042737 | drug catabolic process(GO:0042737) |
1.0 | 8.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.0 | 3.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
1.0 | 4.0 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
1.0 | 5.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.0 | 3.0 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
1.0 | 22.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.0 | 20.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.0 | 12.0 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
1.0 | 3.0 | GO:0002933 | lipid hydroxylation(GO:0002933) omega-hydroxylase P450 pathway(GO:0097267) |
1.0 | 4.0 | GO:0032526 | response to retinoic acid(GO:0032526) |
1.0 | 14.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
1.0 | 24.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.0 | 7.9 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
1.0 | 3.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.0 | 4.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.0 | 2.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.0 | 5.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.0 | 2.0 | GO:1903412 | response to bile acid(GO:1903412) |
1.0 | 3.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.0 | 1.9 | GO:0007320 | insemination(GO:0007320) |
1.0 | 12.6 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
1.0 | 3.9 | GO:0015870 | acetylcholine transport(GO:0015870) |
1.0 | 5.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
1.0 | 2.9 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
1.0 | 8.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
1.0 | 3.8 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
1.0 | 7.7 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
1.0 | 2.9 | GO:0051697 | protein delipidation(GO:0051697) |
1.0 | 2.9 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.9 | 3.8 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.9 | 2.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.9 | 1.9 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.9 | 2.8 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.9 | 10.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.9 | 2.8 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.9 | 3.7 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.9 | 4.6 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.9 | 1.8 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.9 | 12.9 | GO:0060736 | prostate gland growth(GO:0060736) |
0.9 | 11.0 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.9 | 52.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.9 | 3.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.9 | 9.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.9 | 4.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.9 | 2.7 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.9 | 1.8 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.9 | 11.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.9 | 4.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.9 | 2.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.9 | 7.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.9 | 1.8 | GO:0007538 | primary sex determination(GO:0007538) |
0.9 | 9.8 | GO:0042116 | macrophage activation(GO:0042116) |
0.9 | 14.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.9 | 1.8 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.9 | 2.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.9 | 3.5 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.9 | 7.9 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.9 | 3.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.9 | 17.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.9 | 3.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.9 | 3.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.9 | 2.6 | GO:0010927 | cellular component assembly involved in morphogenesis(GO:0010927) |
0.9 | 3.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.9 | 10.4 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.9 | 4.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.9 | 19.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.9 | 1.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.9 | 3.4 | GO:0015793 | glycerol transport(GO:0015793) |
0.8 | 3.4 | GO:0001757 | somite specification(GO:0001757) |
0.8 | 5.9 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.8 | 5.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.8 | 1.7 | GO:0051106 | base-excision repair, DNA ligation(GO:0006288) positive regulation of DNA ligation(GO:0051106) |
0.8 | 1.7 | GO:0030220 | platelet formation(GO:0030220) |
0.8 | 0.8 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.8 | 5.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.8 | 2.5 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.8 | 6.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.8 | 5.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
0.8 | 2.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.8 | 2.5 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.8 | 5.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.8 | 12.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 9.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.8 | 2.4 | GO:0035148 | tube formation(GO:0035148) |
0.8 | 3.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.8 | 4.8 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.8 | 10.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.8 | 4.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.8 | 3.2 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.8 | 4.8 | GO:1903800 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.8 | 4.8 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.8 | 4.8 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.8 | 16.7 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.8 | 11.9 | GO:0019374 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.8 | 3.2 | GO:0044597 | polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.8 | 10.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.8 | 0.8 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.8 | 1.6 | GO:0009584 | detection of visible light(GO:0009584) |
0.8 | 2.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.8 | 2.3 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.8 | 4.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.8 | 1.5 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.8 | 2.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.8 | 3.1 | GO:0051899 | membrane depolarization(GO:0051899) |
0.8 | 31.3 | GO:0098760 | response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.8 | 6.9 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.8 | 3.0 | GO:1990266 | neutrophil migration(GO:1990266) |
0.8 | 0.8 | GO:0042698 | ovulation cycle(GO:0042698) |
0.8 | 3.8 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.8 | 0.8 | GO:0030432 | peristalsis(GO:0030432) |
0.7 | 3.0 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.7 | 2.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.7 | 2.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.7 | 1.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.7 | 1.5 | GO:0030149 | sphingolipid catabolic process(GO:0030149) membrane lipid catabolic process(GO:0046466) |
0.7 | 3.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.7 | 1.5 | GO:0015802 | basic amino acid transport(GO:0015802) basic amino acid transmembrane transport(GO:1990822) |
0.7 | 2.9 | GO:0003335 | corneocyte development(GO:0003335) |
0.7 | 3.7 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.7 | 0.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 4.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 6.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.7 | 8.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.7 | 3.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 11.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.7 | 19.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.7 | 13.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.7 | 5.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.7 | 13.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.7 | 3.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.7 | 33.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.7 | 33.7 | GO:0050776 | regulation of immune response(GO:0050776) |
0.7 | 5.6 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.7 | 4.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.7 | 2.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.7 | 1.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.7 | 2.1 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.7 | 5.6 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.7 | 18.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.7 | 14.5 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.7 | 2.1 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.7 | 37.2 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.7 | 21.3 | GO:0070206 | protein trimerization(GO:0070206) |
0.7 | 2.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.7 | 2.7 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.7 | 5.4 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.7 | 4.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.7 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 9.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 1.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.7 | 15.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.7 | 1.4 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
0.7 | 2.7 | GO:0035082 | axoneme assembly(GO:0035082) |
0.7 | 4.0 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.7 | 2.7 | GO:1905225 | thyroid-stimulating hormone signaling pathway(GO:0038194) response to thyrotropin-releasing hormone(GO:1905225) |
0.7 | 3.3 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.7 | 10.7 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.7 | 4.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.7 | 1.3 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.7 | 3.3 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
0.7 | 11.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.7 | 3.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.7 | 2.0 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.7 | 3.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.7 | 1.3 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) negative regulation of interleukin-17 production(GO:0032700) |
0.7 | 5.9 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.7 | 2.0 | GO:0046219 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
0.7 | 3.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.7 | 3.9 | GO:0097354 | protein prenylation(GO:0018342) protein geranylgeranylation(GO:0018344) prenylation(GO:0097354) |
0.7 | 7.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.6 | 3.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.6 | 3.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.6 | 5.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.6 | 10.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.6 | 1.9 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.6 | 9.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 1.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.6 | 7.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 3.8 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 9.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.6 | 3.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.6 | 32.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.6 | 3.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 3.1 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 1.9 | GO:0014061 | regulation of norepinephrine secretion(GO:0014061) |
0.6 | 19.3 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.6 | 3.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 9.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.6 | 2.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 4.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.6 | 4.8 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.6 | 10.2 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.6 | 2.4 | GO:2000849 | glucocorticoid secretion(GO:0035933) corticosterone secretion(GO:0035934) regulation of glucocorticoid secretion(GO:2000849) regulation of corticosterone secretion(GO:2000852) |
0.6 | 2.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.6 | 3.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 2.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 1.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.6 | 6.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.6 | 1.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.6 | 1.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.6 | 3.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 0.6 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.6 | 4.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 7.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.6 | 8.6 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.6 | 8.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.6 | 2.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 2.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.6 | 1.7 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.6 | 5.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 2.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.6 | 2.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.6 | 6.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.6 | 1.1 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.6 | 1.7 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.6 | 3.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.6 | 9.4 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.6 | 2.8 | GO:0046618 | drug export(GO:0046618) |
0.5 | 1.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.5 | 3.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 2.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 6.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.5 | 3.8 | GO:0051904 | melanosome localization(GO:0032400) establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule localization(GO:0051875) pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
0.5 | 1.6 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.5 | 1.6 | GO:1990123 | L-glutamate import(GO:0051938) amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.5 | 2.7 | GO:0003014 | renal system process(GO:0003014) |
0.5 | 12.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 5.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.5 | 3.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.5 | 4.2 | GO:0000050 | urea cycle(GO:0000050) |
0.5 | 4.2 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.5 | 1.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 1.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 1.1 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.5 | 4.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 1.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.5 | 6.2 | GO:0006906 | vesicle fusion(GO:0006906) |
0.5 | 2.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.5 | 4.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.5 | 4.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 14.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.5 | 7.3 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.5 | 1.6 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.5 | 7.3 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.5 | 3.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.5 | 7.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.5 | 3.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.5 | 2.0 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.5 | 3.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.5 | 10.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.5 | 1.0 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.5 | 18.7 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.5 | 3.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.5 | 13.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.5 | 2.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 9.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.5 | 3.4 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.5 | 11.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 1.5 | GO:0072364 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.5 | 2.4 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.5 | 1.5 | GO:0035564 | regulation of kidney size(GO:0035564) regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) pronephros morphogenesis(GO:0072114) |
0.5 | 3.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.5 | 1.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 2.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.5 | 1.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.5 | 1.4 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.5 | 4.7 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.5 | 10.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.5 | 4.7 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 2.8 | GO:0072538 | T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) |
0.5 | 3.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.5 | 1.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.5 | 2.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.5 | 1.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.5 | 4.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.5 | 4.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 9.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.5 | 2.7 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.5 | 5.4 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.4 | 5.8 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.4 | 22.0 | GO:0042073 | intraciliary transport(GO:0042073) |
0.4 | 2.6 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 0.4 | GO:0070640 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
0.4 | 3.1 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.4 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 3.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.4 | 3.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.4 | 0.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 2.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 3.4 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.4 | 5.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.4 | 1.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.4 | 2.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.4 | 1.3 | GO:0051037 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.4 | 8.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 1.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.4 | 2.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 2.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 2.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) regulation of glucose mediated signaling pathway(GO:1902659) |
0.4 | 3.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 5.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.4 | 4.8 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.4 | 2.8 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.4 | 239.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.4 | 1.6 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.4 | 1.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 5.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.4 | 0.4 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.4 | 1.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.4 | 1.6 | GO:0098930 | axonal transport(GO:0098930) |
0.4 | 3.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 2.7 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 1.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.4 | 1.5 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.4 | 6.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.4 | 11.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 1.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.4 | 2.2 | GO:0097484 | dendrite extension(GO:0097484) |
0.4 | 3.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 0.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 2.6 | GO:0007625 | grooming behavior(GO:0007625) |
0.4 | 1.8 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.4 | 4.4 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.4 | 2.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.4 | 2.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.4 | 3.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.4 | 9.7 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.4 | 3.9 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.4 | 3.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.4 | 2.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 4.9 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.3 | 4.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.3 | 1.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 24.5 | GO:0007586 | digestion(GO:0007586) |
0.3 | 0.7 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.3 | 1.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.3 | 1.0 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.3 | 2.7 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.3 | 2.4 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.3 | 2.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 1.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 3.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.3 | 4.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 1.6 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 2.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.6 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.3 | 1.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 1.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.3 | 2.2 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.3 | 1.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 2.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.3 | 3.5 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.3 | 4.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 0.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 1.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.3 | 2.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 1.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 3.6 | GO:0033198 | response to ATP(GO:0033198) |
0.3 | 0.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.3 | 6.3 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.3 | 3.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 2.7 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.3 | 3.2 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.3 | 1.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.3 | 1.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 2.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 2.0 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 0.8 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.3 | 0.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.3 | 1.9 | GO:0007588 | excretion(GO:0007588) |
0.3 | 1.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) photoreceptor cell differentiation(GO:0046530) |
0.3 | 8.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.3 | 7.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 4.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 2.7 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.3 | 2.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.3 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of terminal mannose on C branch(GO:0036510) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.3 | 1.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 1.1 | GO:0018101 | protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) histone citrullination(GO:0036414) |
0.3 | 1.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 0.8 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.3 | 3.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 1.3 | GO:0072537 | fibroblast activation(GO:0072537) |
0.3 | 9.2 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.3 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 7.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 10.6 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
0.3 | 2.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 5.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 0.3 | GO:0032536 | regulation of cell projection size(GO:0032536) |
0.2 | 5.9 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 2.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 1.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 1.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.2 | 8.5 | GO:0046849 | bone remodeling(GO:0046849) |
0.2 | 2.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 5.3 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 1.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.7 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.2 | 1.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 0.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.2 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
0.2 | 8.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 11.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 1.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 1.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.8 | GO:0050714 | positive regulation of protein secretion(GO:0050714) |
0.2 | 0.4 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.8 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 1.2 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.2 | 9.9 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.2 | 0.2 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.2 | 8.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 4.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 1.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.2 | 2.6 | GO:0032147 | activation of protein kinase activity(GO:0032147) |
0.2 | 0.9 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
0.2 | 4.4 | GO:0000272 | polysaccharide catabolic process(GO:0000272) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 1.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 1.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 2.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 1.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 3.2 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.2 | 0.6 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 0.2 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.2 | 2.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 2.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 1.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 1.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 1.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 3.7 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 1.7 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 1.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 1.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.4 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.2 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 1.1 | GO:0042789 | mRNA transcription(GO:0009299) mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 2.1 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 1.6 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.1 | 1.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.7 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 2.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 2.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 1.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.6 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 2.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 3.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 10.1 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.9 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 1.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.8 | GO:0007369 | gastrulation(GO:0007369) |
0.1 | 1.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.3 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 1.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 1.0 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.3 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 4.0 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.1 | 0.9 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.1 | 0.3 | GO:0098711 | iron ion import into cell(GO:0097459) iron ion import across plasma membrane(GO:0098711) |
0.1 | 0.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 2.6 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.1 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.2 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.1 | 0.3 | GO:2000615 | histone H3-K9 acetylation(GO:0043970) regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 1.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.4 | GO:0044108 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.1 | 0.5 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 2.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 1.5 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.6 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.3 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.3 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.2 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 1.8 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.6 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.0 | GO:0060536 | growth plate cartilage chondrocyte differentiation(GO:0003418) cartilage morphogenesis(GO:0060536) |
0.0 | 1.3 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.4 | 140.7 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
22.8 | 68.4 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
17.8 | 71.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
16.0 | 337.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
14.3 | 14.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
14.0 | 659.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
12.1 | 36.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
11.8 | 82.9 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
11.4 | 79.6 | GO:0019814 | immunoglobulin complex(GO:0019814) |
9.5 | 104.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
6.7 | 33.3 | GO:0036398 | TCR signalosome(GO:0036398) |
6.3 | 31.6 | GO:0001652 | granular component(GO:0001652) |
6.1 | 30.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
5.9 | 35.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
5.6 | 162.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
5.5 | 22.2 | GO:1990745 | EARP complex(GO:1990745) |
5.4 | 21.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
5.3 | 26.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
5.2 | 15.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
4.7 | 94.7 | GO:0001891 | phagocytic cup(GO:0001891) |
4.6 | 37.1 | GO:0032010 | phagolysosome(GO:0032010) |
4.6 | 92.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
4.3 | 26.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
4.3 | 21.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
4.2 | 66.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
4.2 | 20.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
4.0 | 15.9 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
3.9 | 3.9 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
3.9 | 15.4 | GO:0097224 | sperm connecting piece(GO:0097224) |
3.9 | 19.3 | GO:0000801 | central element(GO:0000801) |
3.7 | 14.9 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
3.7 | 44.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
3.6 | 21.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
3.4 | 17.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
3.3 | 13.1 | GO:1990031 | pinceau fiber(GO:1990031) |
3.1 | 6.2 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
3.1 | 42.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
3.0 | 9.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
3.0 | 17.8 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
2.9 | 49.7 | GO:0042627 | chylomicron(GO:0042627) |
2.9 | 11.5 | GO:0097443 | sorting endosome(GO:0097443) |
2.9 | 34.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.6 | 76.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
2.6 | 28.9 | GO:0042629 | mast cell granule(GO:0042629) |
2.6 | 10.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.5 | 42.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
2.4 | 28.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.4 | 7.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.4 | 23.5 | GO:0097486 | multivesicular body lumen(GO:0097486) |
2.3 | 18.6 | GO:0035976 | AP1 complex(GO:0035976) |
2.3 | 7.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.3 | 9.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
2.3 | 79.6 | GO:0008305 | integrin complex(GO:0008305) |
2.2 | 17.8 | GO:0045179 | apical cortex(GO:0045179) |
2.2 | 8.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.2 | 17.6 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
2.2 | 8.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
2.1 | 12.9 | GO:0032280 | symmetric synapse(GO:0032280) |
2.1 | 27.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
2.1 | 91.0 | GO:0001772 | immunological synapse(GO:0001772) |
2.1 | 317.8 | GO:0072562 | blood microparticle(GO:0072562) |
2.1 | 18.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
2.0 | 8.0 | GO:0045298 | tubulin complex(GO:0045298) |
2.0 | 5.9 | GO:0036038 | MKS complex(GO:0036038) |
1.9 | 27.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
1.9 | 5.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.9 | 24.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.9 | 3.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.8 | 5.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.8 | 10.8 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
1.8 | 3.6 | GO:0032797 | SMN complex(GO:0032797) |
1.8 | 37.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.8 | 7.0 | GO:0036128 | CatSper complex(GO:0036128) |
1.7 | 6.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.7 | 10.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.7 | 13.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.6 | 3.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.6 | 8.2 | GO:0089701 | U2AF(GO:0089701) |
1.6 | 24.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.6 | 83.9 | GO:0001533 | cornified envelope(GO:0001533) |
1.6 | 11.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
1.6 | 4.8 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
1.6 | 6.4 | GO:0097449 | astrocyte projection(GO:0097449) |
1.6 | 111.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
1.6 | 6.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.6 | 6.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.6 | 4.7 | GO:0031251 | PAN complex(GO:0031251) |
1.5 | 10.5 | GO:0043203 | axon hillock(GO:0043203) |
1.5 | 17.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
1.5 | 25.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.5 | 10.4 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.5 | 73.1 | GO:0016235 | aggresome(GO:0016235) |
1.5 | 5.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.4 | 2.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.4 | 5.6 | GO:0014802 | terminal cisterna(GO:0014802) |
1.4 | 62.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.4 | 11.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.4 | 2.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.4 | 12.3 | GO:0005827 | polar microtubule(GO:0005827) |
1.4 | 9.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.3 | 22.4 | GO:0097225 | sperm midpiece(GO:0097225) |
1.3 | 13.2 | GO:0097427 | microtubule bundle(GO:0097427) |
1.3 | 5.2 | GO:0044194 | cytolytic granule(GO:0044194) |
1.3 | 11.8 | GO:0016013 | syntrophin complex(GO:0016013) |
1.3 | 10.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.3 | 6.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.3 | 31.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.3 | 5.0 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
1.2 | 7.5 | GO:0002177 | manchette(GO:0002177) |
1.2 | 33.3 | GO:0051233 | spindle midzone(GO:0051233) |
1.2 | 4.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.2 | 3.5 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
1.2 | 8.2 | GO:0032584 | growth cone membrane(GO:0032584) |
1.2 | 7.0 | GO:0043218 | compact myelin(GO:0043218) |
1.2 | 20.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.2 | 5.8 | GO:0097386 | glial cell projection(GO:0097386) |
1.2 | 3.5 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
1.1 | 5.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.1 | 10.2 | GO:0034464 | BBSome(GO:0034464) |
1.1 | 2.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
1.1 | 7.8 | GO:0097433 | dense body(GO:0097433) |
1.1 | 11.1 | GO:0071953 | elastic fiber(GO:0071953) |
1.1 | 5.5 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
1.1 | 1.1 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
1.1 | 14.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.1 | 5.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.1 | 5.5 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
1.1 | 9.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.1 | 3.2 | GO:0070695 | FHF complex(GO:0070695) |
1.0 | 5.2 | GO:0071546 | pi-body(GO:0071546) |
1.0 | 11.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.0 | 6.1 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.0 | 9.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 14.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
1.0 | 3.9 | GO:0033263 | CORVET complex(GO:0033263) |
1.0 | 110.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.0 | 183.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
1.0 | 14.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.0 | 2.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.0 | 122.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.9 | 99.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.9 | 6.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 3.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.9 | 3.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.9 | 13.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.9 | 17.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.9 | 10.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.9 | 8.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.9 | 12.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 42.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.9 | 10.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.9 | 3.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.9 | 12.0 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.8 | 4.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.8 | 5.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.8 | 5.9 | GO:0097361 | CIA complex(GO:0097361) |
0.8 | 3.3 | GO:0031905 | early endosome lumen(GO:0031905) |
0.8 | 2.5 | GO:0044447 | axoneme part(GO:0044447) |
0.8 | 5.8 | GO:0000800 | lateral element(GO:0000800) |
0.8 | 3.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.8 | 4.9 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.8 | 2.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.8 | 4.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.8 | 21.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.8 | 4.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.8 | 5.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 6.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.7 | 96.6 | GO:0016605 | PML body(GO:0016605) |
0.7 | 3.0 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 131.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.7 | 5.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 57.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.7 | 1.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.7 | 2.1 | GO:0098536 | deuterosome(GO:0098536) |
0.7 | 25.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.7 | 48.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.7 | 1.4 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.7 | 6.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.7 | 4.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 2.0 | GO:0060198 | clathrin-sculpted vesicle(GO:0060198) |
0.7 | 0.7 | GO:0001740 | Barr body(GO:0001740) |
0.7 | 4.0 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 2.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 4.7 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.7 | 46.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.7 | 2.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.6 | 1.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 2.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 23.8 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 7.7 | GO:0005922 | connexon complex(GO:0005922) |
0.6 | 5.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.6 | 20.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 1.8 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.6 | 4.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 1.2 | GO:0031906 | late endosome lumen(GO:0031906) |
0.6 | 4.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.6 | 14.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.6 | 14.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.6 | 681.9 | GO:0005615 | extracellular space(GO:0005615) |
0.6 | 4.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 26.3 | GO:0005902 | microvillus(GO:0005902) |
0.6 | 2.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.6 | 7.8 | GO:0031904 | endosome lumen(GO:0031904) |
0.6 | 5.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 9.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 6.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 27.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.5 | 4.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.5 | 11.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 2.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 1.5 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.5 | 10.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 1.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 2.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 16.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.5 | 8.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 8.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.5 | 2.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 3.2 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 12.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.5 | 2.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 6.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 19.0 | GO:0001726 | ruffle(GO:0001726) |
0.4 | 6.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 1.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.4 | 21.9 | GO:0043235 | receptor complex(GO:0043235) |
0.4 | 1.6 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 2.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 3.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 1.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 2.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 4.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 3.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.3 | 4.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 1.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 2.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 6.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 11.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 1.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.3 | 1.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 15.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 14.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 1.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.3 | 17.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 3.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 4.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 17.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 4.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 2.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 3.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 1.6 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 4.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 9.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 1.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 2.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 2.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 1.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 2.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 2.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 261.0 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.2 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 3.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 20.3 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.2 | 5.0 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 3.4 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 0.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 8.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 1.8 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 13.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.6 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.2 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.9 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 2.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 3.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 3.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.7 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 8.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 4.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 3.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 52.7 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 1.4 | GO:0097060 | synaptic membrane(GO:0097060) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.7 | 86.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
21.0 | 147.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
16.5 | 49.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
14.4 | 202.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
14.3 | 14.3 | GO:0001846 | opsonin binding(GO:0001846) |
13.2 | 727.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
12.8 | 38.3 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
12.6 | 50.3 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
11.3 | 22.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
11.1 | 88.9 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
10.9 | 54.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
10.8 | 53.8 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
9.1 | 36.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
8.9 | 115.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
8.9 | 26.7 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
8.8 | 26.4 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
8.5 | 246.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
8.2 | 24.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
8.1 | 32.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
7.6 | 45.8 | GO:0042610 | CD8 receptor binding(GO:0042610) |
7.5 | 67.4 | GO:0043426 | MRF binding(GO:0043426) |
7.3 | 43.8 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
7.2 | 21.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
7.0 | 20.9 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
6.7 | 26.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
6.7 | 20.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
6.7 | 20.0 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
6.3 | 50.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
6.3 | 19.0 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
6.3 | 31.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
6.0 | 96.6 | GO:0019864 | IgG binding(GO:0019864) |
6.0 | 18.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
6.0 | 18.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
5.9 | 17.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
5.6 | 28.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
5.6 | 5.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
5.5 | 22.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
5.4 | 765.2 | GO:0003823 | antigen binding(GO:0003823) |
5.2 | 20.9 | GO:0061714 | folic acid receptor activity(GO:0061714) |
5.2 | 15.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
4.9 | 14.7 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
4.9 | 63.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
4.9 | 34.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
4.9 | 14.6 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
4.8 | 14.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
4.8 | 47.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
4.7 | 14.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
4.5 | 18.0 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
4.5 | 13.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
4.4 | 26.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
4.3 | 69.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
4.3 | 21.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
4.3 | 12.9 | GO:0004040 | amidase activity(GO:0004040) |
4.3 | 4.3 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
4.3 | 25.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
4.2 | 16.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
4.2 | 8.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
4.2 | 33.6 | GO:0030172 | troponin C binding(GO:0030172) |
4.2 | 25.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
4.1 | 12.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
4.0 | 12.1 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
4.0 | 12.0 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
4.0 | 19.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
3.9 | 3.9 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
3.9 | 3.9 | GO:0001855 | complement component C4b binding(GO:0001855) |
3.9 | 55.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
3.9 | 27.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
3.8 | 26.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
3.8 | 26.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
3.8 | 11.3 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
3.7 | 11.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
3.6 | 10.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
3.6 | 18.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
3.6 | 10.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
3.6 | 10.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
3.6 | 21.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
3.5 | 10.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
3.5 | 10.5 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
3.5 | 13.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
3.4 | 6.8 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
3.4 | 10.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
3.4 | 13.4 | GO:0008940 | nitrate reductase activity(GO:0008940) |
3.3 | 29.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
3.3 | 6.6 | GO:0016936 | galactoside binding(GO:0016936) |
3.3 | 13.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
3.3 | 9.9 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
3.2 | 12.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
3.2 | 9.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
3.2 | 16.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
3.1 | 22.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
3.1 | 6.3 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
3.1 | 6.3 | GO:1990254 | keratin filament binding(GO:1990254) |
3.1 | 12.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
3.1 | 9.2 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
3.0 | 12.2 | GO:0019862 | IgA binding(GO:0019862) |
3.0 | 9.1 | GO:0004802 | transketolase activity(GO:0004802) |
3.0 | 9.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.0 | 15.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
2.9 | 8.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.9 | 8.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.9 | 23.3 | GO:0034711 | inhibin binding(GO:0034711) |
2.9 | 8.7 | GO:0070628 | proteasome binding(GO:0070628) |
2.9 | 2.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
2.9 | 11.4 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
2.8 | 8.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.8 | 8.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
2.8 | 50.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
2.8 | 11.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
2.7 | 10.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
2.7 | 18.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.7 | 18.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.7 | 18.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.7 | 8.0 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
2.6 | 7.9 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
2.6 | 18.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
2.6 | 13.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
2.6 | 28.2 | GO:0004875 | complement receptor activity(GO:0004875) |
2.6 | 17.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.5 | 20.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.5 | 30.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.5 | 15.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
2.5 | 7.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
2.5 | 42.4 | GO:0038191 | neuropilin binding(GO:0038191) |
2.5 | 5.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
2.5 | 5.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.5 | 7.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.5 | 7.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.5 | 24.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
2.4 | 4.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
2.4 | 4.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
2.4 | 12.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
2.4 | 9.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
2.4 | 4.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
2.4 | 23.9 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
2.4 | 4.8 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
2.4 | 26.3 | GO:0008430 | selenium binding(GO:0008430) |
2.4 | 7.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.4 | 14.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
2.4 | 7.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
2.4 | 42.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.4 | 4.7 | GO:0051373 | FATZ binding(GO:0051373) |
2.4 | 7.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
2.3 | 9.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
2.3 | 7.0 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
2.3 | 9.3 | GO:0019003 | GDP binding(GO:0019003) |
2.3 | 14.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
2.3 | 11.6 | GO:0097643 | amylin receptor activity(GO:0097643) |
2.3 | 2.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
2.3 | 11.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
2.3 | 6.9 | GO:0032090 | Pyrin domain binding(GO:0032090) |
2.3 | 59.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
2.3 | 6.8 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
2.3 | 25.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
2.3 | 9.0 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.2 | 20.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
2.2 | 11.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
2.2 | 13.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.2 | 9.0 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
2.2 | 33.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.2 | 11.1 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
2.2 | 13.3 | GO:0003796 | lysozyme activity(GO:0003796) |
2.2 | 15.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
2.2 | 8.8 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
2.2 | 6.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
2.2 | 10.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.2 | 10.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
2.1 | 6.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
2.1 | 6.4 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
2.1 | 6.4 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
2.1 | 23.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.1 | 6.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
2.1 | 4.2 | GO:0035473 | lipase binding(GO:0035473) |
2.1 | 18.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
2.1 | 2.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
2.1 | 18.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
2.1 | 8.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
2.1 | 18.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
2.0 | 8.2 | GO:0031628 | opioid receptor binding(GO:0031628) mu-type opioid receptor binding(GO:0031852) |
2.0 | 6.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
2.0 | 8.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
2.0 | 10.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
2.0 | 6.0 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
2.0 | 11.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
2.0 | 5.9 | GO:0048030 | disaccharide binding(GO:0048030) |
2.0 | 5.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.0 | 3.9 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
1.9 | 9.7 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
1.9 | 7.8 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
1.9 | 9.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.9 | 11.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.9 | 34.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.9 | 11.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.9 | 3.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.9 | 5.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.9 | 15.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.9 | 11.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.9 | 11.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.8 | 14.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.8 | 3.7 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
1.8 | 7.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.8 | 27.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.8 | 18.3 | GO:0031433 | telethonin binding(GO:0031433) |
1.8 | 10.9 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
1.8 | 21.8 | GO:0045159 | myosin II binding(GO:0045159) |
1.8 | 1.8 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
1.8 | 19.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.8 | 12.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.8 | 14.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.8 | 3.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.8 | 37.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.8 | 26.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.8 | 22.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.7 | 10.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.7 | 15.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.7 | 10.4 | GO:0045569 | TRAIL binding(GO:0045569) |
1.7 | 6.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.7 | 1.7 | GO:0003909 | DNA ligase activity(GO:0003909) |
1.7 | 5.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.7 | 6.6 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
1.7 | 9.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.7 | 24.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.7 | 6.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.6 | 4.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
1.6 | 8.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.6 | 1.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
1.6 | 4.9 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
1.6 | 19.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.6 | 12.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.6 | 19.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.6 | 38.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.6 | 16.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.6 | 4.8 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
1.6 | 4.8 | GO:0005497 | androgen binding(GO:0005497) |
1.6 | 4.8 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.6 | 12.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.6 | 4.8 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
1.6 | 7.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.6 | 4.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
1.5 | 15.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.5 | 6.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.5 | 7.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
1.5 | 4.6 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
1.5 | 13.7 | GO:0048495 | Roundabout binding(GO:0048495) |
1.5 | 6.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
1.5 | 333.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.5 | 12.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.5 | 7.6 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
1.5 | 6.1 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
1.5 | 15.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.5 | 18.0 | GO:0034452 | dynactin binding(GO:0034452) |
1.5 | 10.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.5 | 8.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.5 | 41.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
1.5 | 39.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.5 | 2.9 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
1.4 | 7.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
1.4 | 2.9 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
1.4 | 9.9 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
1.4 | 7.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.4 | 5.6 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
1.4 | 5.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.4 | 15.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
1.4 | 9.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.4 | 26.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.4 | 13.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.4 | 2.7 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
1.4 | 5.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.4 | 5.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
1.4 | 5.4 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
1.3 | 6.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.3 | 2.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
1.3 | 21.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
1.3 | 8.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.3 | 4.0 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.3 | 23.8 | GO:0070403 | NAD+ binding(GO:0070403) |
1.3 | 5.3 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
1.3 | 5.3 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
1.3 | 7.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.3 | 24.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.3 | 15.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 11.4 | GO:0043199 | sulfate binding(GO:0043199) |
1.3 | 15.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.3 | 36.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.3 | 3.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.3 | 97.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.3 | 16.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.3 | 8.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.3 | 31.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.3 | 2.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.3 | 5.0 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
1.2 | 3.7 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
1.2 | 24.6 | GO:0043495 | protein anchor(GO:0043495) |
1.2 | 3.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
1.2 | 3.7 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
1.2 | 9.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.2 | 7.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.2 | 6.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.2 | 7.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
1.2 | 3.6 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
1.2 | 8.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.2 | 6.0 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
1.2 | 13.2 | GO:0031419 | cobalamin binding(GO:0031419) |
1.2 | 15.5 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.2 | 8.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.2 | 43.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
1.2 | 5.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
1.2 | 7.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.2 | 18.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
1.2 | 3.5 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
1.2 | 5.8 | GO:0030275 | LRR domain binding(GO:0030275) |
1.2 | 19.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.2 | 6.9 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
1.1 | 3.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.1 | 11.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.1 | 11.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.1 | 5.6 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
1.1 | 2.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.1 | 103.3 | GO:0019905 | syntaxin binding(GO:0019905) |
1.1 | 4.4 | GO:0008431 | vitamin E binding(GO:0008431) |
1.1 | 5.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.1 | 4.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.1 | 3.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
1.1 | 56.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.1 | 4.2 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 22.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
1.1 | 3.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.0 | 3.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 20.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
1.0 | 3.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
1.0 | 7.2 | GO:0008142 | oxysterol binding(GO:0008142) |
1.0 | 29.9 | GO:0008009 | chemokine activity(GO:0008009) |
1.0 | 7.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.0 | 8.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.0 | 20.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.0 | 5.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.0 | 5.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
1.0 | 4.0 | GO:0030911 | TPR domain binding(GO:0030911) |
1.0 | 18.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.0 | 4.0 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.0 | 30.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.0 | 10.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.0 | 35.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.0 | 15.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.0 | 3.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.0 | 12.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.0 | 1.9 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
1.0 | 10.6 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
1.0 | 5.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.0 | 4.8 | GO:0050436 | microfibril binding(GO:0050436) |
1.0 | 26.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.0 | 5.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 2.8 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.9 | 9.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.9 | 13.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.9 | 5.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.9 | 8.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.9 | 4.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.9 | 4.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.9 | 1.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.9 | 9.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 2.7 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.9 | 2.7 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.9 | 4.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.9 | 3.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.9 | 2.7 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.9 | 78.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.9 | 16.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.9 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.9 | 11.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.9 | 27.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.9 | 4.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.9 | 13.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.9 | 38.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.9 | 6.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.9 | 6.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.9 | 36.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.8 | 3.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.8 | 1.7 | GO:0043398 | HLH domain binding(GO:0043398) |
0.8 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
0.8 | 6.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.8 | 2.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.8 | 6.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.8 | 75.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.8 | 3.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.8 | 9.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.8 | 9.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.8 | 3.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.8 | 7.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.8 | 2.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.8 | 3.1 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.8 | 1.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.8 | 2.3 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.8 | 0.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.8 | 22.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.8 | 8.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.8 | 2.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.8 | 16.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.8 | 3.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 3.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 5.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.7 | 1.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.7 | 2.9 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.7 | 8.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.7 | 20.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.7 | 11.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.7 | 2.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.7 | 31.8 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.7 | 2.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.7 | 2.2 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.7 | 4.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.7 | 5.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 5.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.7 | 8.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.7 | 9.9 | GO:0016594 | glycine binding(GO:0016594) |
0.7 | 4.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.7 | 4.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.7 | 2.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.7 | 3.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 1.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.7 | 3.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.7 | 35.0 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.7 | 1.4 | GO:0010181 | FMN binding(GO:0010181) |
0.7 | 6.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.7 | 3.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.7 | 4.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 2.0 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.7 | 2.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.7 | 8.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 22.8 | GO:0032451 | demethylase activity(GO:0032451) |
0.7 | 3.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.7 | 4.7 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.7 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 8.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.7 | 11.3 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 4.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 11.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.7 | 3.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.7 | 5.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 3.9 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.6 | 1.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 35.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.6 | 5.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 2.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 3.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 14.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 1.9 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) Rab geranylgeranyltransferase activity(GO:0004663) |
0.6 | 3.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.6 | 1.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 3.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.6 | 9.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 1.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 4.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.6 | 13.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 7.9 | GO:0043178 | alcohol binding(GO:0043178) |
0.6 | 2.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.6 | 1.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.6 | 2.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.6 | 1.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 3.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.6 | 1.8 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.6 | 5.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.6 | 1.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.6 | 4.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.6 | 8.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.6 | 8.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 1.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.6 | 2.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.6 | 11.4 | GO:0071949 | FAD binding(GO:0071949) |
0.6 | 5.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.6 | 7.3 | GO:0019841 | retinol binding(GO:0019841) |
0.6 | 1.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.6 | 2.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 2.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.6 | 2.8 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.5 | 2.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 5.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.5 | 1.6 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.5 | 8.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.5 | 7.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 40.7 | GO:0005179 | hormone activity(GO:0005179) |
0.5 | 2.7 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.5 | 2.1 | GO:0004803 | transposase activity(GO:0004803) |
0.5 | 4.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.5 | 2.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.5 | 1.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.5 | 5.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 9.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 2.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 4.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 7.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.5 | 10.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.5 | 2.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 3.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 2.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.5 | 5.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.5 | 4.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.5 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 8.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 1.4 | GO:0032810 | sterol response element binding(GO:0032810) |
0.5 | 2.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.5 | 6.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 207.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.5 | 1.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 7.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 1.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.5 | 1.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 10.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.5 | 5.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.5 | 8.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 6.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 0.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.4 | 0.9 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.4 | 4.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 2.2 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 3.5 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 10.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 1.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.4 | 3.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 20.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.4 | 7.2 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.4 | 5.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.4 | 1.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.4 | 1.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 2.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 4.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 1.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 6.5 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 2.8 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.4 | 2.0 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.4 | 6.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 2.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 1.2 | GO:0052659 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol trisphosphate kinase activity(GO:0051766) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.4 | 5.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 4.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 1.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.4 | 7.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 2.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 0.8 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.4 | 4.6 | GO:0000149 | SNARE binding(GO:0000149) |
0.4 | 1.2 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.4 | 10.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 1.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 37.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 14.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 10.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.4 | 1.1 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.4 | 1.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.4 | 6.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 1.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 2.2 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 2.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 1.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.3 | 1.0 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.3 | 4.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 5.2 | GO:0043236 | laminin binding(GO:0043236) |
0.3 | 5.7 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 22.5 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.3 | 1.0 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.3 | 2.6 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.3 | 13.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 7.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.3 | 22.5 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.3 | 6.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 79.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 3.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 4.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 3.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 2.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 3.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 2.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 5.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.3 | 2.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.3 | 1.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 23.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 245.5 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.3 | 4.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.4 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.3 | 1.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.3 | 0.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.3 | 8.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 2.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 5.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 11.9 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 8.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 5.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 4.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 7.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 1.2 | GO:0099583 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.2 | 1.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 1.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 6.8 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 0.7 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 2.4 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 4.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 118.6 | GO:0004888 | transmembrane signaling receptor activity(GO:0004888) |
0.2 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 1.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 2.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 2.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 4.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.6 | GO:0046332 | SMAD binding(GO:0046332) |
0.2 | 1.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 1.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.6 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 2.9 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.2 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 1.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 1.7 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.5 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 0.5 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.2 | 5.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 2.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.1 | 1.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 2.2 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.3 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 0.7 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.1 | 0.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 3.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 1.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 4.2 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.1 | GO:0048256 | 5'-flap endonuclease activity(GO:0017108) flap endonuclease activity(GO:0048256) |
0.1 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 0.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 6.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 1.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 5.1 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 1.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.8 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.1 | 1.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 1.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.2 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 3.5 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 3.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 2.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.6 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 1.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.3 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 274.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
4.3 | 108.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
3.8 | 3.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
3.0 | 54.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
3.0 | 21.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
2.9 | 26.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
2.9 | 228.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.7 | 16.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
2.7 | 239.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
2.4 | 36.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.3 | 129.8 | PID BCR 5PATHWAY | BCR signaling pathway |
2.3 | 13.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
2.2 | 9.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.0 | 17.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.9 | 11.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.9 | 7.5 | PID ALK1 PATHWAY | ALK1 signaling events |
1.8 | 46.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.8 | 59.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.8 | 19.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.6 | 6.3 | ST STAT3 PATHWAY | STAT3 Pathway |
1.5 | 23.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.5 | 27.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.5 | 58.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.5 | 31.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.5 | 7.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.5 | 50.6 | ST GAQ PATHWAY | G alpha q Pathway |
1.4 | 21.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.4 | 14.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.3 | 37.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.3 | 72.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.3 | 73.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.3 | 12.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.3 | 3.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.2 | 24.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.2 | 3.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.2 | 10.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.1 | 11.4 | PID EPO PATHWAY | EPO signaling pathway |
1.1 | 7.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.1 | 14.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.1 | 8.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.1 | 183.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.1 | 28.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.0 | 16.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
1.0 | 15.6 | PID IFNG PATHWAY | IFN-gamma pathway |
1.0 | 11.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.0 | 62.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.0 | 18.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.9 | 26.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 10.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.9 | 31.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.9 | 6.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.8 | 22.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.8 | 201.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.8 | 27.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.8 | 7.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.8 | 38.6 | PID FGF PATHWAY | FGF signaling pathway |
0.8 | 1.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.8 | 14.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 5.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.7 | 13.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 38.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.6 | 1.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 17.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 9.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 6.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 14.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 7.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 2.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 10.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.5 | 32.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 9.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 21.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 14.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 5.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 28.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 7.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.4 | 2.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 11.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.4 | 13.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 18.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 5.5 | ST ADRENERGIC | Adrenergic Pathway |
0.4 | 9.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 7.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 15.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 9.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 1.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 29.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 32.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 4.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 15.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 10.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 1.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 5.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 8.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 4.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 42.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.9 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.8 | 385.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
10.2 | 102.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
9.1 | 9.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
8.3 | 74.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
5.7 | 459.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
4.1 | 77.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
3.3 | 3.3 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
3.1 | 12.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
3.0 | 48.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.8 | 14.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
2.7 | 34.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
2.7 | 29.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
2.7 | 39.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.5 | 2.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
2.5 | 4.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
2.3 | 73.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.1 | 29.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.0 | 16.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.0 | 83.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.9 | 11.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.9 | 121.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.9 | 111.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.8 | 47.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.8 | 32.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.8 | 61.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.7 | 34.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.7 | 33.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.6 | 24.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
1.6 | 3.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.6 | 8.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.6 | 49.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.5 | 46.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.5 | 46.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.5 | 81.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.5 | 1.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.5 | 17.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.5 | 27.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.4 | 21.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.4 | 23.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.4 | 8.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.3 | 28.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.3 | 25.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.3 | 30.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.3 | 52.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.3 | 13.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.2 | 7.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
1.2 | 23.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.2 | 38.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.2 | 8.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.2 | 14.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.2 | 57.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.1 | 40.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.1 | 5.7 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
1.1 | 438.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
1.1 | 6.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.1 | 7.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.1 | 26.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.1 | 56.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
1.1 | 13.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.0 | 6.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 179.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.0 | 30.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
1.0 | 20.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.0 | 13.8 | REACTOME DEFENSINS | Genes involved in Defensins |
1.0 | 6.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.9 | 8.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.9 | 17.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.9 | 8.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.9 | 17.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 21.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.9 | 9.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.9 | 2.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 3.4 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.8 | 11.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.8 | 6.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.8 | 6.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.8 | 5.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.8 | 26.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.8 | 105.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.8 | 19.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.8 | 29.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.7 | 14.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 15.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 12.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.7 | 22.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.7 | 26.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.7 | 2.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.6 | 7.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 11.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 9.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.6 | 10.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.6 | 12.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.6 | 12.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 6.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 13.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.6 | 3.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 7.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 5.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 38.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 8.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 7.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.5 | 16.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 6.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 13.6 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.5 | 2.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 35.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 10.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.4 | 9.4 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.4 | 5.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 17.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 2.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 4.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 1.9 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.4 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 5.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 13.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 8.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 13.8 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.3 | 4.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 37.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 2.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 2.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 6.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 12.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 21.3 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.3 | 5.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 5.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 2.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 3.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 2.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.3 | 17.9 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.3 | 3.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 7.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 10.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 1.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 3.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 3.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 1.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 4.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 6.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 1.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 9.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 1.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 1.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 9.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 1.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 4.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 2.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.3 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 2.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 3.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 10.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 2.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 6.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 8.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 3.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 2.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 2.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 4.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |